Effect of preoperative interventions on outcome following liver resection in a rat model of cirrhosis

Journal of Hepatology

Volumn 32, Issue 2, 2000, Pages 287-292

  Moser, Mike ^a,b   Zhang, Manna ^a   Gong, Yuewen ^a   Johnson, James ^a   Kneteman, Norman ^b   Minuk, Gerald Y ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Ciprofloxacin; Cirrhosis; Fibrosis; Herbal medicine; Liver function; Pentoxifylline; Preoperative; Regeneration; Resection

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CELL DNA; CIPROFLOXACIN; COLLAGEN; CYCLINE; PENTOXIFYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHINESE HERB; CONTROLLED STUDY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER REGENERATION; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RAT;

EID: 0033981707     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80074-4     Document Type: Article

References (28)

1. Brenner DA. Therapeutic strategies for hepatic fibrosis. Hepatology. 8:1987;176-182.
2. Friedman SL, Arthur MJ. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest. 84:1989;1780-1795.
3. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest. 84:1989;1786-1793.
4. Peterson TC. Inhibition of fibroproliferation by pentoxifylline: activity of metabolite-1 and lack of role of adenosine receptors. Biochem Pharmacol. 52:1996;597-602.
5. Peterson TC. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatology. 17:1993;486-493.
6. Esposito S, Barbra D, Galante D, Gaeta GB, Laghezza O. Changes in intestinal microflora induced by ciprofloxacin and treatment of portal systemic encephalopathy. Rev Infect Dis. 10:1988;S197.
7. Chrysanthopoulos CJ, Skoutelis AT, Starakis JC, Arvaniti A, Bassaris HP. Use of ciprofloxacin in biliary sepsis. Infection. 16:1988;249.
8. Segev S, Rehavi M, Rubinstein E. Quinolones, theophylline and diclofenac interactions with the γ-aminobutyric acid receptor. Antimicrob Agents Chemother. 1988;1624-1626.
9. Minuk GY, Bear CE, Sarjeant EJ. Sodium-independent bicuculline-sensitive [3H]GABA binding to isolated rat hepatocytes. Am J Physiol. 252:1987;642-647.
10. Minuk GY, Gauthier T. The effect of γ-aminobutyric acid on hepatic regenerative activity following partial hepatectomy in rats. Gastroenterology. 104:1993;217-221.
11. Zhang M, Gong Y, Minuk GY. The effects of ethanol and gamma aminobutyric acid alone and in combination on hepatic regenerative activity in the rat. J Hepatol. 29:1998;638-641.
12. Minuk GY, Gauthier T, Zhang XK, Wang GQ, Pettigrew NM, Burczynski FJ. Ciprofloxacin prevents the inhibitory effects of acute ethanol exposure on hepatic regeneration in the rat. Hepatology. 22:1995;1797-1800.
13. Zhang MN, Guopei S, Minuk GY. Effects of hepatic stimulator substance, herbal medicine, selenium/vitamin E and ciprofloxacin on cirrhosis in the rat. Gastroenterology. 110:1996;1150-1155.
14. Kaita KDE, Assy N, Gauthier T, Zhang M, Meyers A, Minuk GY. The beneficial effects of ciprofloxacin on survival and hepatic regenerative activity in a rat model of fulminant hepatic failure. Hepatology. 27:1998;533-536.
15. Proctor E, Chatamra K. Standardized micronodular cirrhosis in the rat. Eur Surg Res. 16:1984;182-186.
16. Bosma A, Brouwer A, Seifert WF, Knook L. Synergism between ethanol and CC14 in the generation of liver cirrhosis. J Pathol. 156:1988;15-21.
17. Peterson TC, Neumeister M. Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism. Immunopharmacology. 31:1996;183-193.
18. Higgins CM, Andersson RM. Experimental pathology of the liver of the white rat following partial surgical removal. Arch Pathol. 12:1931;186-202.
19. MacIntosh EL, Gauthier T, Pettigrew N, Minuk GY. Hepatic fibrosis as a predictor of hepatic regenerative activity after partial hepatectomy in the rat. Hepatology. 17:1992;307-309.
20. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 19:1995;1409-1417.
21. Luk GD. Essential role of polyamine metabolism in hepatic regeneration. Gastroenterology. 90:1986;1261-1267.
22. Assy N, Gong Y, Zhang M, Pettigrew NM, Pashniak D, Minuk GY. Use of proliferating cell nuclear antigen as a marker of liver regeneration after partial hepatectomy in rats. J Lab Clin Med. 131:1998;251-256.
23. Lowry OH, Rosebrough NJ, Farr AL. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
24. Minuk GY. Gamma-aminobutyric acid and the liver. Dig Dis. 11:1993;45-54.
25. Liu C, Liu P, Xu DM, Zho SC, Yu GS, Wang PY. The experimental study of Taoken against liver cirrhosis. J Chin Tradi. 7:1991;20-23.
26. Ma XH, Zhao YC, Yi L, Hen YW, Xan SQ. The absorption of Denshen against hepatic fibrosis. Chin J Integrated Tradi Wes Med. 2:1988;161-163.
27. Meixia W, Haowei C, Yanjun L, Linmin M, Guolong Z, Kai M. Herbs of the genus phyllanthus in the treatment of chronic hepatitis B: observations with three preparations from different geographic sites. J Lab Clin Med. 126:1995;350-352.
28. Milne A, Hopkirk N, Lucas CR, Waldon J, Foo Y. Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus. NZ Med J. 107:1994;243.